InvestorsHub Logo
Followers 5
Posts 367
Boards Moderated 0
Alias Born 07/08/2011

Re: None

Monday, 03/13/2017 5:16:50 PM

Monday, March 13, 2017 5:16:50 PM

Post# of 387
Fortunately for me I did make a little from this penny stock unlike the majority I have been in especially AEMD. Though I did end up making a little on AEMD after holding for 10 yrs I missed the opportunity to grab over 40k profit on their pumped up Ebola cure of a very ill Dr in Germany.

At least with OGES I grabbed what I could without holding for very long and got the heck out of dodge when I started getting suspicious of their pumped up TV interviews without any follow up. They really put on a good show for a bit last summer and had me believing they really had a winning product in the ever popular lithium battery market and they also was pumping the school mentioned previously for a short stint. The school in itself didn't thrill me so much as a revenue source but I felt it gave the company some legitimacy just like the FDA approving AEMD as an emergency treatment for Ebola did concerning that company though it was another pump by James Joyce that wasn't exactly 100% truthful. He also claimed they sent a Hemopurifier to the Neb hospital that was an approved Ebola facility which he may or may not have actually sent one but it wasn't by request if he did.

Sorry for spewing some sour grapes but it amazes me how these firms get by with walking a fine line between spewing some truth and just outright lies. If most of us operated our own lives the way these people operate we would be tarred and feathered actually sued, fined or possibly jail time. I know before I retired and owned an insurance and securities firm we were so restricted in what was appropriate/ legal to say/present to clients and even our business cards, phone listings, advertising, ect... was heavily scrutunized and needed compliance approval.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.